| Dr John D Burk, MD | |
|
516 Pegram Dr, Tupelo, MS 38801-6347 | |
| (662) 844-6272 | |
| (662) 844-1603 |
| Full Name | Dr John D Burk |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 516 Pegram Dr, Tupelo, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518991033 | NPI | - | NPPES |
| 00123008 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 7919 (Mississippi) | Primary |
| Entity Name | Dermatology Center Of North Ms Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053491605 PECOS PAC ID: 7416006986 Enrollment ID: O20090513000267 |
News Archive
An interview with James Flanaghan, discussing the uses of DREADDs in neurobiological research and the advantages of water-soluble ligands.
UNAIDS has been strongly encouraged by groundbreaking new study results showing that the antiretroviral medicine cabotegravir administered by an injection every two months – prevents HIV among women.
Viamet Pharmaceuticals, Inc. announced today the initiation of the phase 2 clinical program for its antifungal agent VT-1161. The initial phase 2 study is designed to evaluate the safety and efficacy of VT-1161 in the treatment of vulvovaginal candidiasis (VVC) and is being conducted at leading clinical centers in the United States.
A new study led by a research team from Massachusetts Eye and Ear and Harvard Medical School describes how bacteria adapted to the modern hospital environment and repeatedly cause antibiotic-resistant bloodstream infections.
Researchers have identified important risk factors for death and transplantation in children with dilated cardiomyopathy, according to results from a study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John D Burk, MD 516 Pegram Dr, Tupelo, MS 38801-6347 Ph: (662) 844-6272 | Dr John D Burk, MD 516 Pegram Dr, Tupelo, MS 38801-6347 Ph: (662) 844-6272 |
News Archive
An interview with James Flanaghan, discussing the uses of DREADDs in neurobiological research and the advantages of water-soluble ligands.
UNAIDS has been strongly encouraged by groundbreaking new study results showing that the antiretroviral medicine cabotegravir administered by an injection every two months – prevents HIV among women.
Viamet Pharmaceuticals, Inc. announced today the initiation of the phase 2 clinical program for its antifungal agent VT-1161. The initial phase 2 study is designed to evaluate the safety and efficacy of VT-1161 in the treatment of vulvovaginal candidiasis (VVC) and is being conducted at leading clinical centers in the United States.
A new study led by a research team from Massachusetts Eye and Ear and Harvard Medical School describes how bacteria adapted to the modern hospital environment and repeatedly cause antibiotic-resistant bloodstream infections.
Researchers have identified important risk factors for death and transplantation in children with dilated cardiomyopathy, according to results from a study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.
› Verified 3 days ago
Dr. Bradley Noel Greenhaw, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 516 Pegram Dr, Tupelo, MS 38801 Phone: 662-844-6272 Fax: 662-844-1603 | |
Dr. Jeffrey C Houin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 516 Pegram Dr, Tupelo, MS 38801 Phone: 662-844-6272 Fax: 662-844-1603 |